![]() |
Volumn 46, Issue 5, 2002, Pages 1204-1211
|
Fitness cost of chromosomal drug resistance-conferring mutations
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 DEOXYSTREPTAMINE;
AMINOCYCLITOL;
ANTIBIOTIC AGENT;
BACTERIAL PROTEIN;
LINCOSAMIDE DERIVATIVE;
MACROLIDE;
MIKAMYCIN B;
STREPTOMYCIN;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIUM ISOLATE;
BACTERIUM MUTANT;
CHROMOSOME MUTATION;
CONTROLLED STUDY;
GENE MUTATION;
IN VITRO STUDY;
MYCOBACTERIUM SMEGMATIS;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN SYNTHESIS;
ANTI-BACTERIAL AGENTS;
CHROMOSOMES, BACTERIAL;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
MUTATION;
MYCOBACTERIUM SMEGMATIS;
RIBOSOMAL PROTEINS;
RRNA OPERON;
SELECTION (GENETICS);
STREPTOMYCIN;
|
EID: 0036237703
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: 10.1128/AAC.46.5.1204-1211.2002 Document Type: Article |
Times cited : (177)
|
References (42)
|